|
|
|
|
Keratitis - New keratitis study findings recently were reported by researchers at Moorfields Eye Hospital
In this recent article published in the journal Ophthalmology, scientists in London, the United Kingdom conducted a study 'To assess the relative risks (RR) of microbial keratitis (MK) for contemporary contact lens (CL) types and wearing...
|
|
|
Keratitis - Researchers at University of New South Wales release new data on keratitis
In this recent article published in the journal Ophthalmology, scientists in Sydney, Australia conducted a study 'To establish the absolute risk of contact lens (CL)-related microbial keratitis, the incidence of vision loss and risk factors...
|
|
|
Keratitis After PRK Enhancement Post-LASIK
By Mitchell A.Jackson, MD; Karl G. Stonecipher, MD; Walter J. Stark, MD; and William B. Trattler, MD CASE PRESENTATION A 42-year-old male underwent LASIK in both eyes approximately 1 year ago. His preoperative manifest refraction...
|
|
|
Heat-Inactivated Microbicide in Lens Solution Linked to Fungal Keratitis Epidemic
NEW YORK (Reuters Health) Nov 10 - The world-wide Fusarium keratitis epidemic of 2004-2006 has been attributed to inadequate temperature control during storage and transport of contact lens solution.Now, researchers in Ohio report that...
|
|
|
AAO/SOE 2008: Ganciclovir Gel Allows Fewer Relapses in Patients With Herpetic Keratitis
_ AAO/SOE 2008: Ganciclovir Gel Allows Fewer Relapses in Patients With Herpetic Keratitis.
|
|
|
Contact Lens-Related Acanthamoeba Keratitis in a Patient With Chronic Fatigue Syndrome
hanji V et al.- This case report highlights the fact that concurrent incapacitating illnesses like CFS may not allow proper care of contact lenses thereby making patients prone to contact lens-related corneal infections. --- OPHTHALMIC...
|
|
|
The Risk of Microbial Keratitis With Newer Contact Lenses
_ The Risk of Microbial Keratitis With Newer Contact Lenses.
|
|
|
Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Tre
TAMPA, Fla., Nov.3 /PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that studies of two investigational drugs in development for treatment of potentially blinding...
|
|
|
Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Tre
TAMPA, Fla., Nov.3 /PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that studies of two investigational drugs in development for treatment of potentially blinding...
|
|
|
Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Tre
TAMPA, Fla., Nov.3 /PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that studies of two investigational drugs in development for treatment of potentially blinding...
|
|
|
Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Tre
TAMPA, Fla., Nov.3 /PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that studies of two investigational drugs in development for treatment of potentially blinding...
|
|
|
Durezol in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatme
/PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that studies of two investigational drugs in development for treatment of potentially blinding eye diseases will be...
|
|
|
Durezol in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatme
/PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that studies of two investigational drugs in development for treatment of potentially blinding eye diseases will be...
|
